New blood test could spot leukemia return months earlier

This study is testing a new, highly sensitive blood test (digital PCR) to find tiny amounts of leukemia cells that remain after a stem cell transplant in people with acute myeloid leukemia (AML). The goal is to see if this test can predict a relapse earlier than current methods. About 100 participants will have their blood checked at several time points over the first year after transplant. The study does not provide a treatment, but aims to improve how doctors monitor for disease return.